DAIC

FEBRUARY 21, 2024

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

DAIC

JUNE 24, 2024

Photo by Cedars-Sinai milla1cf Mon, 06/24/2024 - 20:17 June 24, 2024 — Aakriti Gupta, MD , and Michelle Kittleson, MD, PhD , cardiologists in the Smidt Heart Institute at Cedars-Sinai , have been selected to join the senior editorial team of the Journal of the American College of Cardiology (JACC), effective July 1.

Heart Failure 100

Heart Failure Transplant Interventional Cardiology Research 100

DAIC

APRIL 30, 2024

Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Cardiology Update

APRIL 9, 2024

The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure. In contrast, outcomes were better in patients with HF with reduced EF (HFrEF).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Cardiology Update

JANUARY 22, 2024

Long-term outcomes were assessed at the eight highest-enrolling sites. The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. Secondary outcomes were experienced by 77.7% N Engl J Med 2024; 390:212-220.

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

DAIC

APRIL 6, 2024

Gregg Stone, MD “When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. Researchers tracked outcomes in each participant for at least one year and up to two years.

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146828-A4146828, November 12, 2024. Heart transplantation remains a vital treatment for end-stage heart failure, yet the scarcity of suitable donor hearts makes the treatment unavailable to many patients in critical need.

Transplant 40

Transplant Heart Transplant Heart Dysfunction Heart Failure 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146920-A4146920, November 12, 2024. Cox regression results showed that there is an increased risk of mortality in patients who did not receive transfusions before transplant (p<0.0001).Conclusion:While

Transplant 40

Transplant Heart Transplant Risk Factors Outcomes 40

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 5 Kutty, S., et al (2016).

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

The American Journal of Cardiology

JULY 6, 2024

Publication date: Available online 6 July 2024 Source: The American Journal of Cardiology Author(s): Jacob Agronin, Meredith Brown, Hannah Calvelli, Huaqing Zhao, Val Rakita, Yoshiya Toyoda, Mohammed Abul Kashem

Heart Transplant 40

Heart Transplant Transplant Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020. Patients without CHD were older (mean age 71.5

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , The CMS coverage approval is supported by the scientific rigor of the protocol design and the results from the interim data from the CardiAMP Heart Failure Trial recently presented at the Technology and Heart Failure Therapeutics 2024 annual meeting.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page ASa1109-ASa1109, November 12, 2024. We assessed the correlates of predicted peak VO2, and the relationship between predicted peak VO2quartiles and cardiovascular outcomes (death/transplant).Results:Of 15.2 - 23.9) 1.69, p<0.001).Conclusions:The

Transplant 40

Transplant Outcomes Exercise Cardiovascular Disease 40

DAIC

APRIL 6, 2024

Gregg Stone, MD “When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. Researchers tracked outcomes in each participant for at least one year and up to two years.

Heart Failure 75

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 75

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144326-A4144326, November 12, 2024. It has changed the fate of young patients with large tumors who would have otherwise needed heart transplants, offering high suture strength and reducing postoperative complications. During a median follow-up period of 17.4

Pediatrics 40

Pediatrics Outcomes Heart Transplant Aneurysm 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4113494-A4113494, November 12, 2024. End-stage ischemic heart disease necessitates heart transplantation, and emerging cell therapy presents a promising solution to address donor scarcity.

Ischemia 40

Ischemia Transplant Heart Transplant Biomarkers 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP286-ATP286, February 1, 2024. Introduction:Intraparenchymal stem cell transplantation shows therapeutic promise for chronic ischemic stroke patients. Visium identified specific gene clusters for the stroke injury, transplant/needle-track, stem cell graft, and the cortical ‘FLAIR’ region.

Transplant 40

Transplant Stroke Strokes Research 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142247-A4142247, November 12, 2024. Background:Cardiac transplantation remains the single most effective treatment for end-stage heart failure. Autoradiography revealed68Ga-grazytracer accumulation in the transplanted heart. at POD 7 days; P<0.001).

Transplant 40

Transplant Heart Failure Circulation Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145296-A4145296, November 12, 2024. Aortic valve stenosis (AS) is often a contraindication to liver transplantation (LT). Aortic valve peak velocity (AVVmax) increased steadily as patients neared transplant and dropped significantly immediately after transplantation (Figure 1A).

Aortic valve 40

Aortic valve Aortic Transplant Stenosis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A146-A146, February 1, 2024. However, whether and how a high salt diet (HSD) impacts long-term stroke outcomes - even after salt reduction/withdrawal prior to a stroke is unknown.Methods:Intracerebral hemorrhage (ICH) was modeled by blood or collagenase injections in mice.

Hemorrhage 40

Hemorrhage Transplant Diet Stroke 40

All About Cardiovascular System and Disorders

FEBRUARY 24, 2024

A study published in JACC has compared the phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathy [2]. Heart failure, heart transplantation and death by cardiac causes were more often seen in individuals with biventricular phenotype compared to isolated left or right ventricular phenotype.

Cardiomyopathy 52

Cardiomyopathy Chest Pain Arrhythmia Heart Transplant 52

Circulation: Cardiovascular Imaging

DECEMBER 16, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 12 , Page e016882, December 1, 2024. In patients without a history of repaired congenital heart disease (n=88), only RVFW-LS/PASP, PVRi, PASP, and RVFW-LS/PVRi predicted outcomes (area under the curve, 0.738 [P=0.002], 0.729 [P=0.01], 0.729 [P=0.01], and 0.729 [P=0.015], respectively).CONCLUSIONS:In

Pediatrics 40

Pediatrics Pulmonary Hypertension Congenital Heart Disease 40

Journal of the American Heart Association

DECEMBER 14, 2024

Journal of the American Heart Association, Volume 13, Issue 24 , December 17, 2024. Primary outcomes included changes in Kansas City Medical Optimization score, left ventricular ejection fraction, and cardiovascular eventfree survival (unplanned HF hospitalization, left ventricular assist device /heart transplant, or death).

Heart Failure 40

Heart Failure Heart Transplant Echocardiogram Transplant 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4134590-A4134590, November 12, 2024. We collected demographic, pre-procedural, procedural, and outcome-related variables. We aim to describe the rate of MAE in children with cardiomyopathy undergoing cardiac catheterization. were females.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP67-AWMP67, February 1, 2024. CPB is utilized for heart and lung transplants, aorta repairs, valve surgeries, mass resections, and coronary artery bypass grafting (CABG) which alone accounts for 400k patients per year. CMBs are acquired by patients undergoing cardiopulmonary bypass (CPB).

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Transplant Patient Care Research 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139383-A4139383, November 12, 2024. Background:Immunosuppressive (IS) therapy is currently used as first-line treatment for heart transplant (HTx) rejection. However, they are not without complications, and less toxic therapies are needed. years, males: 58.4%).

Heart Transplant 40

Heart Transplant Transplant Cardiovascular Disease Outcomes 40

DAIC

JUNE 24, 2024

milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. , The Cordella platform is the first and only PA pressure-guided platform to offer comprehensive patient management using daily PA pressure and vital signs from home to guide therapeutic management and improve patient outcomes.

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP118-ATMP118, February 1, 2024. Therefore, an aged dysbiotic maternal biome may increase stroke risk factors among offspring and additionally, worsen stroke outcome. Additionally, male offspring from dysbiotic mothers have a worsened stroke outcome.

Stroke 40

Stroke Strokes Outcomes Transplant 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4138589-A4138589, November 12, 2024. All patients were prospectively followed for development of new outcome/cardiac events which included hospitalization for acute HF, CVS-related death, heart transplantation, and also diabetic complications.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Heart Transplant Tricuspid 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP321-AWP321, February 1, 2024. Background:Our recent studies show that transplants of intestine epithelial stem cells (IESCs) promote acute and long term recovery after stroke in middle-aged rats.

Stroke 40

Stroke Strokes Transplant Outcomes 40

European Journal of Heart Failure

DECEMBER 1, 2024

Summary of key study outcomes. Methods and results This single-centre retrospective study examined midterm (180 days) outcomes of patients with CS supported by Impella 5+ who achieved heart recovery. Between June 2022 and April 2024, 20 patients with CS (64 ± 8.9 years, The objective of the study is to examine whether Impella 5.0/5.5

Cardiogenic Shock 40

Cardiogenic Shock Heart Transplant Outcomes Transplant 40

Dr. Malcolm Kendrick

OCTOBER 30, 2024

Burning torches will be provided to all those who turn up. 1: [link] 2: [link] 3: KINGS BENCH DIVISION IN THE HIGH COURT Claim Nos. plus drug supply Bayer: £1.8M plus drug supply ASCEND PLUS (2021 – ongoing) Novo Nordisk A/S: £39.4M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M

Cholesterol 145

Cholesterol Article Research Diet 145